Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
about
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaNeoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.Therapy of cancer by cytokines mediated by gene therapy approach.Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host oGene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.Development of a novel adenovirus-alphavirus hybrid vector with RNA replicon features for malignant hematopoietic cell transduction.Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy.Cell-specific expression of the analgesic-antitumor peptide coding sequence under the control of the human α-fetoprotein gene promoter and enhancer.Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ.Tumor Restrictions to Oncolytic Virus.
P2860
Q26772315-9DA69CA8-C916-4E24-8E32-3B925B976D6BQ35766493-D7A390C8-EC98-40A5-B8EE-DEC270D85728Q36220613-3587D448-4212-4B7F-8D63-A44F34976DF0Q36394987-0FC8C4E1-A0AE-4C4B-8EEE-126C23F85A82Q37452091-4D2ED246-2D19-472E-9E85-FA8A23B84DFFQ38266429-3BE47B80-0B60-47CB-860D-4DE0EFF49FCBQ38703318-1730FEAE-5DED-4DAC-A38A-6480A3A2F1EEQ38760486-2F6F506F-407A-4F19-8848-2AF4E4C42824Q39130225-1C3BBA79-918C-44EA-BB4C-0659A8654E68Q39806537-3692DAF4-36FD-4C98-AC86-43917B4DDC7CQ41828019-CD61AA3C-956C-4281-B8CC-1E110A7B40D6Q47093975-C9659C1E-314D-478F-97EC-5FE48D131CA2Q51846287-86C1F793-CEFE-439C-BC38-BA56223BE8FA
P2860
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Increased efficacy and safety ...... irus-alphavirus hybrid vector.
@en
type
label
Increased efficacy and safety ...... irus-alphavirus hybrid vector.
@en
prefLabel
Increased efficacy and safety ...... irus-alphavirus hybrid vector.
@en
P2093
P50
P1433
P1476
Increased efficacy and safety ...... virus-alphavirus hybrid vector
@en
P2093
Celia Gomar
Cheng Qian
M Gabriela Kramer
Pilar Alzuguren
Stefan Kochanek
P304
P356
10.1158/0008-5472.CAN-05-0877
P407
P577
2006-02-01T00:00:00Z